Cardiac surgery-associated XXXX in a developing country: Prevalence, risk factors and outcome.

@entity1 @entity295 @entity810 @entity1011 @entity551
Little is known about cardiac surgery-associated @entity810 (CS-AKI) in @entity1 in developing regions of the world. The study aimed to determine the prevalence of CSAKI, associated factors and its impact on mortality and utilization of hospital services. The hospital records of @entity1 aged 0-17 years who underwent CS at an Indian hospital were reviewed. CS-AKI was defined as a rise in serum @entity1011 of >= 0.3 mg/dL in any 48 h and or by urine output <0.5 mL/kg/h for an 8-h period in the first five days after CS. The study included 323 @entity1 with a median age of one year (0.04-17), of whom 22 (6.8%) were neonates and 18.3% had a single ventricle. About 60% of the @entity1 had Risk Adjusted Congenital Heart Surgery-I category 1 or 2 interventions. CS-AKI occurred in 39 @entity1 (12.1%). Factors associated with CS-AKI were @entity295 and intraand post-operative @entity551 . In-hospital mortality was six-fold higher in @entity1 who developed CS-AKI. CS-AKI was associated with two to three days more of mechanical ventilation and Intensive care unit stay. CS-AKI occurs in @entity1 in developing countries, but at a lower frequency mainly due to the predominance of post-neonatal @entity1 undergoing less-complex CSs. CS-AKI was associated with higher in-hospital mortality and increased utilization of hospital services. Factors associated with CS-AKI included intraand post-operative @entity551 and @entity295 .
